Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 4:15 PM ET

Capital Markets

Company Overview of Tekla Life Sciences Investors

Company Overview

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of b...

2 Liberty Square

9th Floor

Boston, MA 02109

United States

Founded in 1992





Key Executives for Tekla Life Sciences Investors

Principal Executive Officer, President, Trustee and Member of Valuation Committee
Age: 62
Principal Financial Officer, Chief Compliance Officer, Secretary and Treasurer
Age: 47
Assistant Treasurer
Age: 43
Compensation as of Fiscal Year 2015.

Tekla Life Sciences Investors Key Developments

Tekla Life Sciences Investors Declares Special Cash Distribution, Payable on January 8, 2016

On December 18, 2015, Tekla Life Sciences Investors declared a special cash distribution of $0.71 per share in order to satisfy annual tax distribution requirements. The record date for the distribution is December 30, 2015 and the payable date is January 8, 2016. The Fund will trade ex-distribution on December 28, 2015.

Tekla Life Sciences Investors Declares Stock Distribution, Payable on June 30, 2015

On May 15, 2015, Tekla Life Sciences Investors declared a stock distribution of $0.54 per share. The record date for the stock distribution is May 27, 2015 and the payable date is June 30, 2015. The Fund will trade ex-distribution on May 22, 2015.

Tekla Life Sciences Investors, Annual General Meeting, Jun 04, 2015

Tekla Life Sciences Investors, Annual General Meeting, Jun 04, 2015., at 08:30 US Eastern Standard Time. Location: Downtown Harvard Club of Boston. Agenda: To propose the election of trustees of fund; to consider the ratification or rejection of the selection of Deloitte & Touche LLP as the independent registered public accountants of fund for the fiscal year ending September 30, 2015; and to consider the transaction of such other business as may properly come before the annual meeting and any adjournment(s) or postponement(s) thereof.

Similar Private Companies By Industry

Company Name Region
Murapa Capital Partners, LLC United States
Industrial Capital Strategies United States
Nikko Asset Management Americas, Inc., Investment Banking Arm United States
SCS Financial Services, LLC United States
Deutsche Bank Global Markets United States

Recent Private Companies Transactions

Private Placement
July 1, 2015
Afferent Pharmaceuticals, Inc.
Private Placement
June 12, 2015
CytomX Therapeutics, Inc.
Private Placement
June 10, 2015
ARCA biopharma, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tekla Life Sciences Investors, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at